RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Gimv
G

Gimv portfolio

Gimv has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Kinaset Therapeutics's $103M Series B+ round in January 2026, alongside Willett Advisors LLC, Vivo Capital, Sixty Degree Capital and 6 others. That company is in Health and bio. It has co-invested with Atlas Venture, Schroders Capital and RA Capital Management, most often Atlas Venture (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $143M.
Latest deal: Kinaset Therapeutics · Jan 9, 2026.

What Gimv invests in

How Gimv invests

StageDealsCapital in rounds
Series B+ 1 50%$103M
Series A 1 50%$40M
YearDealsCapital in rounds
2020 1 50%$40M
2026 1 50%$103M

Share is of the 2 rounds on Recent Funding that name Gimv. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Gimv portfolio companies

CompanyRound with GimvTotal raisedLatest raise
KKinaset Therapeutics
Health and bio
Series B+ · $103M$143MJan 9, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Gimv, which is a subset of its real portfolio. API: /api/v1/investors/gimv (get a free API key). More: the most active VC firms and new venture capital funds.